Biofrontera (BFRI) Assets Average (2021 - 2025)
Biofrontera's (BFRI) quarterly Assets Average came in at $22.0 million in Q4 2025, up 8.28% year-on-year from $20.3 million in Q4 2024, and up 23.69% quarter-over-quarter from $17.8 million in Q3 2025.
Biofrontera (BFRI) Assets Average (2021 - 2025) Analysis & Trends
Biofrontera's Assets Average history runs 5 years deep, the most recent figure standing at $22.0 million for Q4 2025.
- On a quarterly basis, Assets Average rose 8.28% year-over-year to $22.0 million in Q4 2025; TTM through Dec 2025 was $22.0 million, a 8.28% increase from a year earlier, with the FY2025 full-year figure at $25.3 million, up 1.26% from the prior year.
- Assets Average climbed to $22.0 million in Q4 2025 per BFRI's latest filing, from $17.8 million in the prior quarter.
- Across five years, Assets Average topped out at $54.3 million in Q3 2022 and bottomed at $7.7 million in Q4 2021.
- The 5-year median for Assets Average is $23.1 million (2024), against an average of $29.0 million.
- Across the five-year window, Assets Average surged 589.64% in 2022 and slumped 43.45% in 2024, its largest moves.
- Year by year, Assets Average stood at $7.7 million in 2021, then jumped by 589.64% to $53.0 million in 2022, then plunged by 41.44% to $31.0 million in 2023, then plunged by 34.53% to $20.3 million in 2024, then grew by 8.28% to $22.0 million in 2025.
- Per Business Quant, the three latest BFRI Assets Average figures stand at $22.0 million (Q4 2025), $17.8 million (Q3 2025), and $18.4 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Biofrontera | 12.70 Mn | 6.29 Mn | 14.09 Mn | 21.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.99 Mn |
| Sep 30, 2025 | 17.78 Mn |
| Jun 30, 2025 | 18.37 Mn |
| Mar 31, 2025 | 19.34 Mn |
| Dec 31, 2024 | 20.31 Mn |
| Sep 30, 2024 | 20.05 Mn |
| Jun 30, 2024 | 23.07 Mn |
| Mar 31, 2024 | 26.25 Mn |
| Dec 31, 2023 | 31.02 Mn |
| Mar 31, 2023 | 46.42 Mn |
| Dec 31, 2022 | 52.97 Mn |
| Sep 30, 2022 | 54.34 Mn |
| Jun 30, 2022 | 51.41 Mn |
| Mar 31, 2022 | 24.61 Mn |
| Dec 31, 2021 | 7.68 Mn |